Evoke Pharma (EVOK)

$5.13 -0.61 (-10.55%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	8.56M
Revenue (ttm)	10.25M
Net Income (ttm)	-5.35M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-52.20%
Debt to Equity Ratio	0.00

Volume	241,700
Avg Vol	2,897,784
Day's Range	N/A - N/A
Shares Out	1.49M
Stochastic %K	35%
Beta	-0.04
Analysts	Hold
Price Target	$10.00

Company Profile

Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was i...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 858 345 1494

Website: www.evokepharma.com

Address:

420 Stevens Avenue, Suite 230, Solana Beach, United States

Diwndizwj Jul. 16 at 9:47 AM

$EVOK The 1.4 trillion transaction price is 140 times the market capitalization. I can't see the division of power, and I think I'm breaking up ants with a small transaction price, so I'm going to go over $10 soon

0 · Reply